Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

asx emv

  • Home
  •  
  • asx emv



  • Most Read
  • Latest Comments
  • EMVision takes key step in advancing stroke diagnosis technology
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • EMVision takes key step in advancing stroke diagnosis technology
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • EMVision takes key step in advancing stroke diagnosis technology
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • EMVision takes key step in advancing stroke diagnosis technology
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • EMVision takes key step in advancing stroke diagnosis technology
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • EMVision takes key step in advancing stroke diagnosis technology
    EMVision takes key step in advancing stroke diagnosis technology
    • News

  • EMVision analysis confirms hyperacute and acute ischaemia stroke detection capabilities
    EMVision analysis confirms hyperacute and acute ischaemia stroke detection capabilities
    • News

  • EMVision names brain scanner device emu to signal future-first approach
    EMVision names brain scanner device emu to signal future-first approach
    • News

  • EMVision takes key step in advancing stroke diagnosis technology
    • News

    EMVision takes key step in advancing stroke diagnosis technology

    Medical device company EMVision (ASX: EMV) has reported “excellent” results from a study gauging the effectiveness of its cutting-edge neurodiagnostic technology for the identification of stroke and stroke types. The multi-site study – known as EMView – involved the testing of diagnostic algorithms on unseen data from 307 participants across the Liverpool, Royal Melbourne, and

    Read More
    Public
  • EMVision analysis confirms hyperacute and acute ischaemia stroke detection capabilities
    • News

    EMVision analysis confirms hyperacute and acute ischaemia stroke detection capabilities

    Ischaemia is a condition in which the blood supply to any part of the body is so severely restricted that it receives no oxygen and can result in a stroke. Early detection is crucial, and so, medical devices company EMVision (ASX: EMV) has been conducting multi-site clinical trials to advance its neurodiagnostic AI algorithms to

    Read More
    Public
  • EMVision names brain scanner device emu to signal future-first approach
    • News

    EMVision names brain scanner device emu to signal future-first approach

    The Australian bird Emu is known for many things—for instance, it’s not a commitment kind of bird, with its relationships typically lasting for only about five months. Even so, Emus set a great example for couples in post-pregnancy, as the male and female Emus share the load after an egg is hatched, with the male

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.